Private equity consortium tries to acquire Valeant’s iNova

Private equities Pacific Equity Partners and The Carlyle Group are likely to create a consortium targeting the acquisition of iNova Pharmaceuticals. iNova was acquired by Valeant in 2011 for AUD6250m and could now be sold for AUD1bn, experts say. (Source: The Australian)